Delivery Order SPE2DB20D7059-SPE2DB25FQLT7
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bridion 200mg/2ml, a pharmaceutical product, with a ceiling value of $34,244.12. The contract is a firm fixed price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- This is a $1,215.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a medical product, with a period of performance through February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $17,337.60 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The order is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a specialty pharmaceutical product. This delivery order is issued under an existing Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of...
- This is a $15,519.16 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BRIDION 200 MG/2 ML VIAL 2ML pharmaceutical products. The award is not set aside. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical care medical supplies to support military treatment facilities and federal healthcare programs. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) valued up...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,822.12 contract is for the supply of Bridion 200 mg/2 ml vial medication, with a period of performance through May 14, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
- This is a $12,029.31 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Bridion 200 mg/2 ml vials, a specialty medication used in healthcare settings. The contract has an ultimate completion date of April 25, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $7,337.37 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRIDION 200 MG/2 ML VIAL 2ML medical products. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide BRIDION 200 MG/2 ML VIAL 2ML medical supplies. The $3,108.45 contract has an ultimate completion date of March 29, 2024. AmerisourceBergen Drug Corp, the prime contractor, is an experienced pharmaceutical and medical supply provider to the U.S. Department of Defense. This delivery order is part...
- This is a $22,024.35 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of BRIDION 200 MG/2 ML VIAL 2ML medical supplies, with a performance period running through April 3, 2025. The contract was not set aside for any specific business category. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,753.59 firm fixed-price delivery order is for the supply of BRIDION 500 MG/5 ML VIAL 5ML, a medication used in healthcare settings. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQLT7Delivery Order
The Defense Logistics Agency awarded a $12,008.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Bridion is a pharmaceutical reversal agent used in anesthesia recovery, and this delivery order fulfills a specific medical supply need within the federal healthcare system. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and federal healthcare systems through its comprehensive IDC with the DLA. The company's contract portfolio demonstrates extensive experience supplying brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency and other government healthcare programs globally. This delivery order is one of numerous competitive awards the company fulfills under its prime vendor arrangement, reflecting its established capability to meet federal procurement requirements for pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 7/18/25 |